Page last updated: 2024-10-17

bupropion and Granulomatous Disease, Chronic

bupropion has been researched along with Granulomatous Disease, Chronic in 1 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altschuler, EL1
Kast, RE1

Other Studies

1 other study available for bupropion and Granulomatous Disease, Chronic

ArticleYear
Bupropion for Blau syndrome.
    Medical hypotheses, 2004, Volume: 62, Issue:2

    Topics: Arthritis; Bupropion; Carrier Proteins; Chromosome Disorders; Crohn Disease; Dopamine Uptake Inhibit

2004